Literature DB >> 15727968

A model designed to enhance informed consent: experiences from the HIV prevention trials network.

Cynthia Woodsong1, Quarraisha Abdool Karim.   

Abstract

HIV prevention research in developing countries has resulted in increased attention to and discussion of ethical issues, particularly the issue of the quality of informed consent. We present a conceptual framework for an enhanced informed consent process, drawing on experiences garnered from domestic and international studies conducted by the HIV Prevention Trials Network, funded by the National Institutes of Health. This framework guides the development of an informed consent process designed to help ensure initial and continued comprehension of research participation, with an emphasis on HIV prevention research. Attention is focused at the individual and community levels and on 3 study phases: preenrollment, enrollment, and postenrollment.

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2005        PMID: 15727968      PMCID: PMC1449193          DOI: 10.2105/AJPH.2004.041624

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  48 in total

1.  What makes clinical research ethical?

Authors:  E J Emanuel; D Wendler; C Grady
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Reflections and recommendations on research ethics in developing countries.

Authors:  S R Benatar
Journal:  Soc Sci Med       Date:  2002-04       Impact factor: 4.634

3.  Improving the readability of informed consent documents.

Authors:  Beverly Heinze-Lacey; Carol Saunders; Alan Sugar
Journal:  IRB       Date:  1993 May-Jun

4.  Consent for continuing research participation: what is it and when should it be obtained?

Authors:  Dave Wendler; Jonathan Rackoff
Journal:  IRB       Date:  2002 May-Jun

5.  Ethical challenges in international HIV prevention research.

Authors:  Kathleen M MacQueen; Katharine Shapiro; Quarraisha Abdool Karim; Jeremy Sugarman
Journal:  Account Res       Date:  2004 Jan-Mar       Impact factor: 2.622

6.  Research and informed consent in Africa--another look.

Authors:  C B IJsselmuiden; R R Faden
Journal:  N Engl J Med       Date:  1992-03-19       Impact factor: 91.245

7.  Therapeutic misconception and the appreciation of risks in clinical trials.

Authors:  Charles W Lidz; Paul S Appelbaum; Thomas Grisso; Michelle Renaud
Journal:  Soc Sci Med       Date:  2004-05       Impact factor: 4.634

8.  Trust, The fragile foundation of contemporary biomedical research.

Authors:  N E Kass; J Sugarman; R Faden; M Schoch-Spana
Journal:  Hastings Cent Rep       Date:  1996 Sep-Oct       Impact factor: 2.683

9.  Dry sex in Zimbabwe and implications for condom use.

Authors:  D Civic; D Wilson
Journal:  Soc Sci Med       Date:  1996-01       Impact factor: 4.634

10.  Balancing rigour and acceptability: the use of HIV incidence to evaluate a community-based randomised trial in rural Uganda.

Authors:  Kirstin Mitchell; Sarah Nakamanya; Anatoli Kamali; James A G Whitworth
Journal:  Soc Sci Med       Date:  2002-04       Impact factor: 4.634

View more
  44 in total

1.  A Twenty-Two-Year-Old Community Advisory Board: Health Research as an Opportunity for Social Change.

Authors:  Anthony J Silvestre; Sandra J Quinn; Charles R Rinaldo
Journal:  J Community Pract       Date:  2010-01-01

2.  Correlates of lower comprehension of informed consent among participants enrolled in a cohort study in Pune, India.

Authors:  Neelam S Joglekar; Swapna S Deshpande; Seema Sahay; Manisha V Ghate; Robert C Bollinger; Sanjay M Mehendale
Journal:  Int Health       Date:  2012-12-30       Impact factor: 2.473

3.  Applying research ethics guidelines: the view from a sub-saharan research ethics committee.

Authors:  Gail E Henderson; Amy L Corneli; David B Mahoney; Daniel K Nelson; Charles Mwansambo
Journal:  J Empir Res Hum Res Ethics       Date:  2007-06       Impact factor: 1.742

4.  Using formative research to develop a context-specific approach to informed consent for clinical trials.

Authors:  Amy L Corneli; Margaret E Bentley; James R Sorenson; Gail E Henderson; Charles van der Horst; Agnes Moses; Jacqueline Nkhoma; Lyson Tenthani; Yusuf Ahmed; Charles M Heilig; Denise J Jamieson
Journal:  J Empir Res Hum Res Ethics       Date:  2006-12       Impact factor: 1.742

Review 5.  Ethical issues in stem cell research.

Authors:  Bernard Lo; Lindsay Parham
Journal:  Endocr Rev       Date:  2009-04-14       Impact factor: 19.871

6.  When a serious adverse event in research occurs, how do other volunteers react?

Authors:  Caitlin E Kennedy; Nancy Kass; Rachel K Myers; Edward J Fuchs; Charles Flexner
Journal:  J Empir Res Hum Res Ethics       Date:  2011-06       Impact factor: 1.742

7.  Tailoring information provision and consent processes to research contexts: the value of rapid assessments.

Authors:  Susan Bull; Bobbie Farsides; Fasil Tekola Ayele
Journal:  J Empir Res Hum Res Ethics       Date:  2012-02       Impact factor: 1.742

Review 8.  Ethical considerations in HIV cure research: points to consider.

Authors:  Bernard Lo; Christine Grady
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

9.  Behavioral and social science research to support development of educational materials for clinical trials of broadly neutralizing antibodies for HIV treatment and prevention.

Authors:  Pablo K Valente; Yumeng Wu; Yehuda Z Cohen; Marina Caskey; Kathrine Meyers
Journal:  Clin Trials       Date:  2020-08-24       Impact factor: 2.486

10.  Ancillary care in South African HIV vaccine trials: addressing needs, drafting protocols, and engaging community.

Authors:  Catherine M Slack
Journal:  J Empir Res Hum Res Ethics       Date:  2014-02       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.